Bristol-Myers Squibb

10 Most Popular Drug Companies That Hedge Funds Love
Seeking Alpha
Sat, 08/27/11 - 01:06 pm
JNJ
Pfizer
Sanofi
Merck
Abbott Laboratories
Bristol-Myers Squibb
Eli Lilly
Novartis
Impax Labs
Anthera
Time to Sell Bristol-Myers Squibb?
Motley Fool
Sat, 08/27/11 - 01:04 pm
Bristol-Myers Squibb
Does Bristol-Myers Squibb Look Like a Winning Investment?
Motley Fool
Wed, 08/24/11 - 10:01 pm
Bristol-Myers Squibb
Pfizer & Bristol-Myers to Release Highly Anticipated Data on Bloodthinner Hopeful
Motley Fool
Wed, 08/24/11 - 10:19 am
Pfizer
Bristol-Myers Squibb
Eliquis
bloodthinners
Apixaban
Data may prove Bristol, Pfizer drug a winner
Yahoo/Reuters
Mon, 08/22/11 - 11:40 am
Pfizer
stroke
Bristol-Myers Squibb
bloodthinners
Eliquis
Apixaban
7 Large-Cap Global Pharma Dividend Stocks May Provide Appreciation and Income
Seeking Alpha
Sat, 08/20/11 - 10:21 pm
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
GSK
Merck
Sanofi
Pfizer
7 Large-Cap Global Pharma Dividend Stocks May Provide Appreciation and Income
Seeking Alpha
Fri, 08/19/11 - 09:08 am
dividends
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GSK
Merck
Pfizer
Sanofi
Top 10 Biotech Companies to Buy to Beat the Down Economy
Seeking Alpha
Thu, 08/18/11 - 05:33 pm
Abbott Laboratories
Amgen
Bristol-Myers Squibb
GSK
Jazz Pharmaceuticals
Eli Lilly
Merck
Novartis
Pfizer
Questcor Pharmaceuticals
8 Defensive High-Yield Pharmaceuticals to Consider
Seeking Alpha
Thu, 08/18/11 - 12:29 pm
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
JNJ
Novartis
Pfizer
Sanofi
What Happened to U.S. Pharma?
Motley Fool
Sat, 08/13/11 - 02:59 pm
JNJ
Bristol-Myers Squibb
Eli Lilly
Merck
Vertex Pharmaceuticals
Pfizer
Mead Johnson
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Analyst sees low physician expectations for new Gilead HIV treatment Complera
Yahoo/AP
Thu, 08/11/11 - 11:10 am
Gilead
HIV
Complera
JNJ
Atripla
Bristol-Myers Squibb
Drug Maker Dividend Stocks With Strong Growth Prospects
Seeking Alpha
Wed, 08/10/11 - 10:47 am
Pfizer
Merck
Bristol-Myers Squibb
Novartis
Takeda
Sanofi
Eli Lilly
GSK
Roche
AstraZeneca
dividends
Yervoy may face Roche rival sooner than expected
Fierce Pharma
Tue, 08/9/11 - 06:29 pm
Bristol-Myers Squibb
Zelboraf
melanoma
Yervoy
Roche
Will Bristol-Myers Squibb Earn or Burn?
Motley Fool
Mon, 08/8/11 - 01:22 pm
Bristol-Myers Squibb
7 High-Yield, Large-Cap Pharmas to Consider
Seeking Alpha
Thu, 08/4/11 - 10:18 am
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GSK
Merck
Pfizer
Sanofi
U.S. Food and Drug Administration Approves Subcutaneous Formulation of ORENCIA® (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis
Yahoo/BusinessWire
Sat, 07/30/11 - 10:40 am
Orencia
rheumatoid arthritis
Bristol-Myers Squibb
Bristol-Myers Grows in the Wrong Places
Motley Fool
Sat, 07/30/11 - 10:00 am
Bristol-Myers Squibb
earnings
5 Pharma Stocks to Buy as Patents Expire
TheStreet.com
Fri, 07/29/11 - 09:46 am
patents
Merck
Pfizer
Bristol-Myers Squibb
JNJ
Eli Lilly
Yervoy hits the market with $95M bang
Fierce Pharma
Fri, 07/29/11 - 09:44 am
Yervoy
Bristol-Myers Squibb
melanoma

Pages